Pediatrics (Drug Therapy)
Experimental AIDS Drug Now Available To Some Children
Published in AIDS Weekly, July 21st, 1997
Early clinical trials of the drug 1592 indicate it penetrates the central nervous system, according to a statement by Glaxo Wellcome Inc. Researchers are studying the drug to examine its effect on HIV related neurological diseases.
The U.S. Food and Drug Administration (FDA) agreed to make the drug available to desperate children while scientists continue testing. Only a limited number of patients who meet very strict criteria are allowed into clinical trials of drugs. Dying patients outside...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-07-21)
More Articles from AIDS Weekly
- Conference Coverage (SPIRAT/NCDDG-HIV)
Even Brief HAART Stop Lets HIV Re-Seed Lymph Nodes - Conference Coverage (SPIRAT/NCDDG-HIV)
Cord-Blood Studies Prepare for Gene Therapy, Stem-Cell Replacement - Conference Coverage (SPIRAT/NCDDG-HIV)
Cyclophilin: A Cellular Target for Anti-HIV Drugs - Conference Coverage (SPIRAT/NCDDG-HIV)
HIV CTL Escape Mechanism "Bad News" For AIDS Vaccines - Conference Coverage (SPIRAT/NCDDG-HIV)
Trials of HIV and HBV CTL Vaccines Underway in HIV+ Patients - AIDS Therapies
High-Priced Protease Inhibitor Treatments Beginning To Outpace Funding - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
